Moderna mRNA-1273 Vaccine for COVID-19
The market is expected to open DOWN today. Moderna’s (MRNA) stock price, however, is expected to post gains as news coming from the company is highly encouraging.
Moderna announced progress on the late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against COVID-19.
Based on feedback from the . . .
This content is for paid subscribers.
Impacting News
June 11, 2020
